ARCHIVES

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

This article is from The Cancer Letter archive.

Vol. 24 No. 06 | February 13, 1998

Download PDF Visit The Full Archive

Related Articles

Obituary: Joseph Burchenal, 93, A Leader In Cancer Drug Development at MSKCC.

March 17, 2006

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55

November 25, 1983

ACS Supports NCI’s Bypass Budget In Resolution

March 20, 1992

Anna Barker Named Deputy Director for Strategic Scientific Initiatives

December 6, 2002